“Atopic dermatitis disease biomarkers strongly correlate with IL-13 levels, are regulated by IL-13, and are modulated by tralokinumab in vitro”, J of Skin, vol. 3, p. S42, Nov. 2019, doi: 10.25251/skin.3.supp.42.